Table 1 Clinical baseline characteristics
Variable | 100 cm2 < VFA < 150 cm2 | VFA ≥ 150 cm2 | P value |
|---|---|---|---|
Number | N = 28 | N = 41 | |
Age, year | 32.4 (8.84) | 33.7 (11.1) | 0.604 |
Female sex, n (%) | 19 (68%) | 29 (71%) | 0.797 |
Weight, kg | 106 (20.3) | 109 (21.4) | 0.613 |
Height, cm | 166 (7.15) | 166 (6.93) | 0.851 |
Body mass index, kg/m2 | 38.4 (6.27) | 38.9 (5.53) | 0.76 |
Body surface area, m2 | 2.18 (0.20) | 2.26 (0.28) | 0.171 |
Obesity year | 13.5 (9.4) | 14.1 (10.2) | 0.814 |
Diabetes mellitus, n (%) | 10 (36%) | 30 (73%) | 0.003 |
Medication usage, n (%) | 2 (20%) | 7 (23%) | NA |
Dyslipidemia, n (%) | 18 (64%) | 30 (73%) | 0.441 |
Medication usage, n (%) | 3 (17%) | 6 (20%) | NA |
Steatosis, % | 23 (82%) | 39 (95%) | 0.111 |
Systolic blood pressure, mmHg | 130 (5.4) | 132 (9.1) | 0.429 |
Diastolic blood pressure, mmHg | 75.6 (8.2) | 78.6 (9.1) | 0.289 |
AST, U/l | 25.0 (15.4) | 33.3 (17.6) | 0.043 |
ALT, U/l | 30.9 (22.3) | 43.7 (31.6) | 0.053 |
Elevated AST, ALT, n (%) | 4 (14%) | 18 (44%) | 0.017 |
GGT, U/l | 34.9 (15.1) | 56.9 (40.2) | 0.002 |
Elevated GGT, n (%) | 2 (7%) | 14 (34%) | 0.010 |
Platelets, 1000/mm3 | 297 (45.1) | 287 (59.6) | 0.432 |
Albumin, g/l | 43.3 (3.74) | 41.5 (3.64) | 0.044 |
Glucose, mmol/l | 5.18 (0.77) | 7.04 (3.17) | 0.001 |
Glycated hemoglobin, % | 5.64 (0.75) | 6.94 (1.92) | < 0.001 |
Total cholesterol, mmol/l | 4.91 (0.85) | 5.45 (0.90) | 0.013 |
Triglycerides, mmol/l | 1.33 (0.54) | 3.04 (4.65) | 0.025 |
High-density lipoprotein, mmol/l | 1.19 (0.16) | 1.06 (0.23) | 0.009 |
Low-density lipoprotein, mmol/l | 2.82 (0.61) | 3.05 (0.81) | 0.186 |
HOMA-IR | 5.77 (2.58) | 8.63 (4.55) | 0.001 |
NFS | − 2.48 (1.46) | − 1.91 (1.48) | 0.123 |